Sarcoma cancer patients not receiving same protection from Covid-19 as healthy population due to Pfizer vaccine spacing: Sarcoma UK, the national bone and soft tissue cancer charity, is concerned to hear that a new study suggests cancer patients are not receiving the same protection as others against Covid-19 following one does of the Pfizer vaccine. […]
Read More… from Sarcoma patients overlooked in vaccine protection
WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access: The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago. The WHO’s Emergency […]
Read More… from WHO issues validation for a COVID-19 vaccine
Less than half of people currently willing to get a COVID-19 vaccine, international survey suggests: A new report on the public’s attitudes towards coronavirus vaccines has revealed that around half of those surveyed (51%) may be willing to get vaccinated next year. Findings from a survey of 13,500 people across 15 countries* in November suggest that […]
Read More… from Less than 50% willing to get a COVID-19 vaccine
AMNESTY INTERNATIONAL: Wealthy countries already hoarding breakthrough vaccines Responding to the announcement by Pfizer-BioNTech that the COVID-19 vaccine it is developing has been found to be effective in 90 percent of people, Tamaryn Nelson, Amnesty International’s Researcher on the Right to Health, said: “It is great news that the Pfizer-BioNTech vaccine is proving effective against […]
Read More… from Wealthy countries hoarding breakthrough vaccines